NCI-H23 In Vitro TRAP Assay (Senescence)

CAT#: ITS-0123-YF1517
Target Cell Organism: Human
Target Cell Alternative Name: H23
Target Cell Name: NCI-H23
Assay Type: Cellular Senescence in Cancer Assays
Assay Overview
This assay is to provide NCI-H23-based In Vitro TRAP Assay (Senescence) to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
NCI-H23
Target Cell Organism
Human
Target Cell Background
NCI-H23 [H23] is an epithelial-like cell that was isolated from the lung of a Black, 51-year-old, male patient with adenocarcinoma. This cell line was deposited by AF Gazdar and JD Minna and can be used in toxicology and cancer research.
Target Cell Alternative Name
H23
Related Diseases
Non Small Cell Lung Cancer
Research Area
Oncology
Assay Name
In Vitro TRAP Assay (Senescence)
Assay Description
The telomerase repeated amplification protocol (TRAP) assay is one of the common PCR-based assays used to detect telomerase activity in cells.
Assay Alternative Names
Telomerase Repeated Amplification Protocol Assay
Assay Type
Cellular Senescence in Cancer Assays
Assay Type Details
Cell senescence is described as an irreversible physiological event of cell growth arrest, which is known to be caused by alterations of telomeres, oxidative stress, DNA damage and some oncogenes. Inhibition of the program of senescence is one of the main features of tumor cells and it has been reported that cancer cells can be induced to undergo senescence by chemo- and radiotherapies and genetic alterations. Telomeres help to prevent uncontrolled cell proliferation and the absence of telomeres results in aneuploidy and cell death.
Assay Subtype
TRAP Assay
For Research Use Only | Not For Clinical Use
Online Inquiry